Clinical Trials for Malignant Melanoma

Find clinical trials for malignant melanoma. Discover research opportunities and treatment options in your area.

32 Active Trials Found

Showing 32 trials on this page

Page 1 of 2

A Clinical Study of V940 and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

NCT ID: NCT06961006

This clinical trial is studying a new combination treatment for advanced melanoma, which is a serious form of skin cancer that has spread and cannot be removed by surgery. The researchers want to f...

Recruiting

Phase: PHASE2 Type: interventional Locations: Jerusalem, , Israel, Petah Tikva, , Israel +5 more

A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies

NCT ID: NCT06974734

This clinical trial is looking at a new treatment called PF-08046037, either by itself or combined with another drug called sasanlimab, for patients with certain advanced cancers. Specifically, the...

Recruiting

Phase: PHASE1 Type: interventional Locations: Grand Rapids, Michigan, United States, Rio Piedras, , Puerto Rico

A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors

NCT ID: NCT06799533

This clinical trial is studying a new medicine called PF-08046031, which is being tested for safety and effectiveness in treating advanced melanoma and other solid tumors. These are types of cancer...

Recruiting

Phase: PHASE1 Type: interventional Locations: Denver, Colorado, United States, Orlando, Florida, United States +4 more

Reducing Symptom Burden Through Physical Exercise in Melanoma Patients

NCT ID: NCT06985056

This clinical trial is studying whether regular exercise can help reduce fatigue and improve the quality of life for adult patients with advanced melanoma (stage IIb-IV) who are undergoing specific...

Not yet recruiting

Phase: NA Type: interventional Locations: Essen, , Germany

Video-Tumorboard PLUS

NCT ID: NCT06980740

The Video-Tumorboard PLUS clinical trial is designed to improve how patients with malignant melanoma receive expert cancer care through a virtual system. In this trial, doctors from different speci...

Recruiting

Type: observational Locations: Bonn, , Germany, Dresden, , Germany +1 more

RAPA-201 Therapy of Solid Tumors

NCT ID: NCT05144698

The RAPA-201 clinical trial is studying a new type of immunotherapy for patients with advanced solid tumors, including various types of lung, breast, gastric, and head and neck cancers, among other...

Recruiting

Phase: PHASE1 Type: interventional Locations: Hackensack, New Jersey, United States

Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy

NCT ID: NCT06976021

This clinical trial is studying new ways to measure how well certain cancer treatments work, specifically for patients with advanced cancers like triple negative breast cancer, cervical cancer, mel...

Not yet recruiting

Phase: PHASE2 Type: interventional

Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

NCT ID: NCT06708455

This clinical trial is studying a new type of treatment called RAPA-201 cell therapy for patients with advanced malignant melanoma, a serious skin cancer that has spread and has not responded to pr...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Hackensack, New Jersey, United States, Murray, Utah, United States

Study of IK-595 in RAS- or RAF-altered Advanced Tumors

NCT ID: NCT06270082

This clinical trial is studying a new treatment called IK-595 for patients with advanced solid tumors that have specific gene changes in the RAS or RAF pathways. This includes cancers like colorect...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Nashville, Tennessee, United States +15 more

SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)

NCT ID: NCT04079166

The SCOPE Study is a clinical trial aimed at understanding if two experimental cancer vaccines, SCIB1 and iSCIB1+, can be safely combined with existing melanoma treatments, nivolumab (Opdivo) with ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Leeds, , United Kingdom, Manchester, , United Kingdom +14 more

STK-012 Monotherapy and in Combination Therapy in Patients With Solid Tumors

NCT ID: NCT05098132

This clinical trial is looking at a new treatment called STK-012 for patients with certain advanced solid tumors, which are types of cancer that form in various organs. The trial will test STK-012 ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States +18 more

Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

NCT ID: NCT02828202

This clinical trial, called MELBASE, is focused on studying advanced melanoma, which is a serious type of skin cancer. The goal is to gather important information about patients with different stag...

Recruiting

Type: observational Locations: Villejuif, , France, Grenoble, , France +28 more

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

NCT ID: NCT06150664

This clinical trial is studying a new treatment called CTX-8371 for patients with advanced cancers, including non-small cell lung cancer, triple-negative breast cancer, Hodgkin lymphoma, head and n...

Recruiting

Phase: PHASE1 Type: interventional Locations: Buffalo, New York, United States, Boston, Massachusetts, United States +5 more

A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma

NCT ID: NCT03116412

This clinical trial is studying whether regular imaging tests, like scans, during follow-up after surgery for high-risk melanoma can help improve patients' chances of survival. High-risk melanoma i...

Recruiting

Phase: NA Type: interventional Locations: Uppsala, , Sweden, Stockholm, , Sweden +20 more

Study to Evaluate LB-LR1109 for the Treatment of Solid Tumors

NCT ID: NCT06332755

This clinical trial is investigating a new treatment called LB-LR1109 for patients with certain types of advanced cancer, including non-small cell lung cancer, head and neck cancer, kidney cancer, ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Fairfax, Virginia, United States

GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2

NCT ID: NCT05130255

The GD2-SADA:177Lu-DOTA clinical trial is studying a new treatment for patients with certain types of solid tumors, including Small Cell Lung Cancer, Malignant Melanoma, Sarcoma, and High-Risk Neur...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Duarte, California, United States +6 more

Preoperative Planning With PSMA-PET in Melanoma Surgery Trial

NCT ID: NCT06560905

The Preoperative Planning With PSMA-PET in Melanoma Surgery Trial is a study looking at a new way to help detect cancer spread (metastases) in men with malignant melanoma, a type of skin cancer. Th...

Not yet recruiting

Phase: PHASE2 Type: interventional

Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract

NCT ID: NCT05478876

This clinical trial is studying a new treatment called carbon ion radiation therapy for women with mucous melanomas in the lower genital tract. Melanomas are a type of skin cancer, but in this case...

Recruiting

Phase: NA Type: interventional Locations: Pavia, , Italy

A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Cadonilimab Injection and Temozolomide in Second-line and Subsequent Treatment of Advanced Melanoma

NCT ID: NCT06553781

This clinical trial is studying a new treatment approach for patients with advanced malignant melanoma, specifically for those who have not had success with their previous treatments. The trial is ...

Not yet recruiting

Phase: NA Type: interventional

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

NCT ID: NCT06265025

This clinical trial is studying a new treatment called GM103, which is given by injection directly into tumors. The goal is to see how safe this treatment is and if it can help patients with advanc...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of +3 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions